arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Airsculpt Technologies, Inc.

AIRS
$5.01 ▲ +0.25 (+5.25%) at close
Industrials ·Services-Offices & Clinics of Doctors of Medicine ·USServices-Offices & Clinics of Doctors of Medicine
22 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
29
Health
Poor
Bearish
auto_awesome

Analytical Summary

Airsculpt Technologies, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $348.0M
Dividend Yield
Revenue Growth 0.0%
Op. Margin -4.6%
ROIC -1.0%
FCF / Share $0.08
Trailing P/E
Price / Book 3.5x
FCF Yield 1.5%
Debt / Equity 0.45
info Valuation on last close. End-of-day price, Aug 7, 2026.

22-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$39.39M
— 0.0%
Net Income Profit after all expenses
$-2.40M
↑ +15.8%
Operating Margin Operating profit as % of sales
-4.6%
↓ -51.9% 17th
FCF / Share Free cash flow per share
$0.08
↑ +1258.6%
Long-Term Debt Long-term obligations
$44.82M
↓ -20.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
21
Returns
32
Financial Health
42
Cash Quality
20

Dividend History

Dividend / share · sourced from SEC filings
$0.41 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 22 quarters